Recall of Philips Heartstart XL+ Defibrillator/ Monitor

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Philips Medical Systems (USA).

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    16159
  • Event Initiated Date
    2014-02-07
  • Event Country
  • Event Source
    NZMMDSA
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Philips New Zealand Commercial Limited, Level 3, 123 Carlton Gore Road, Newmarket, AUCKLAND 1023
  • Reason
    We have discovered through customer feedback and internal testing that the heartstart xl+ battery charge time to 100% capacity at 35°c (95°f) is slightly longer than the specified 3 hour duration stated in the existing product labelling. since the xl+ can operate with a partially charged battery, there is no patient risk associated with a longer battery charge time.
  • Action
    Instructions for use to be updated

Device

Manufacturer

  • Manufacturer Parent Company (2017)
  • Source
    NZMMDSA